95 related articles for article (PubMed ID: 340821)
1. [C. albicans spontaneous mutations determining 5-fluorocytosine resistance].
Pawlik B; Barylak J
Med Dosw Mikrobiol; 1977; 29(4):301-7. PubMed ID: 340821
[No Abstract] [Full Text] [Related]
2. Segregation of 5-fluorocytosine-resistance variants by Candida albicans.
Whelan WL; Beneke ES; Rogers AL; Soll DR
Antimicrob Agents Chemother; 1981 Jun; 19(6):1078-81. PubMed ID: 7023383
[TBL] [Abstract][Full Text] [Related]
3. [Sensitivity of yeasts against 5 fluorocytosine. Comparison of five methods (author's transl)].
Brinkmann F
Z Hautkr; 1981 Oct; 56(19):1255-63. PubMed ID: 7032101
[TBL] [Abstract][Full Text] [Related]
4. Observations on 5-fluorocytosine and Candida albicans.
Davies RR; Savage MA
Sabouraudia; 1974 Nov; 12(3):302-8. PubMed ID: 4610822
[No Abstract] [Full Text] [Related]
5. [Sensitivity of Candida strains to selected antifungal antibiotics].
Jurek M; Dzierzanowska D
Pol Tyg Lek; 1984 Sep; 39(38):1269-71. PubMed ID: 6390387
[No Abstract] [Full Text] [Related]
6. [Sensitivity in vitro of opportunist yeasts (Candida albicans and Torulopsis glabrata) to flucytosine and concordance curves (author's transl)].
Slim A; Bergogne-Berezin E; Courtoux D
Ann Biol Clin (Paris); 1978; 36(2):69-74. PubMed ID: 358866
[TBL] [Abstract][Full Text] [Related]
7. Complementation analysis of resistance to 5-fluorocytosine in Candida albicans.
Whelan WL; Markie D; Kwon-Chung KJ
Antimicrob Agents Chemother; 1986 May; 29(5):726-9. PubMed ID: 3524427
[TBL] [Abstract][Full Text] [Related]
8. Evidence for sequential action of amphotericin B and 5-fluorocytosine on Canida albicans ATCC 11651.
Beggs WH; Andrews FA; Sarosi GA
Res Commun Chem Pathol Pharmacol; 1977 Mar; 16(3):557-60. PubMed ID: 322227
[No Abstract] [Full Text] [Related]
9. [A simple medium for 5-fluorocytosine sensitiving testing (author's transl)].
Böhm W
Dermatol Monatsschr; 1982 May; 168(5):317-20. PubMed ID: 7049776
[No Abstract] [Full Text] [Related]
10. 5-Fluorocytosine--current status with special references to mode of action and drug resistance.
Polak A
Contrib Microbiol Immunol; 1977; 4():158-67. PubMed ID: 342192
[No Abstract] [Full Text] [Related]
11. [Concentration-contact time relationship in the effect of antimycotic drug combinations (clotrimazole, nystatin, 5-fluorocytosine) and the effect of increasing and decreasing antimycotic drug concentrations on Candida albicans].
Rumler W; Heins S
Mykosen; 1985 May; 28(5):251-7. PubMed ID: 3892290
[No Abstract] [Full Text] [Related]
12. [Sensitivity and resistance of pathogenic yeasts to 5-fluoropyrimidines. I.--Relation between the phenotypes of resistance to 5-fluorocytosine, the serotype of Candida albicans and the ecology of various species of Candida of human origin (author's transl)].
Drouhet E; Mercier-Soucy L; Montplaisir S
Ann Microbiol (Paris); 1975; 126B(1):25-39. PubMed ID: 1108732
[TBL] [Abstract][Full Text] [Related]
13. Candida albicans resistance to 5-fluorocytosine: frequency of partially resistant strains among clinical isolates.
Defever KS; Whelan WL; Rogers AL; Beneke ES; Veselenak JM; Soll DR
Antimicrob Agents Chemother; 1982 Nov; 22(5):810-5. PubMed ID: 6758690
[TBL] [Abstract][Full Text] [Related]
14. The susceptibility of Candida albicans to amphotericin B, nystatin, and 5-fluorocytosine.
Hamra LK; Pankiewicz IJ
Med J Aust; 1977 Nov; 2(22):749-50. PubMed ID: 347230
[TBL] [Abstract][Full Text] [Related]
15. [Action mechanism of 5-fluorocytosine. IV. Morphological observation and development of the resistant cells].
Arai T; Mikami Y; Kawada T; Masuda K
Nihon Saikingaku Zasshi; 1975 Jan; 30(1):257. PubMed ID: 765563
[No Abstract] [Full Text] [Related]
16. [Antimycotic activity in vitro and in vivo of 5-fluorocytosine on pathogenic strains of Candida albicans and Cryptococcus neoformans].
Costa AL; Valenti A; Costa G; Calogero F
G Batteriol Virol Immunol; 1976; 69(7-12):244-9. PubMed ID: 800772
[TBL] [Abstract][Full Text] [Related]
17. Pathogenicity in mice of strains of Candida albicans with different in vitro sensitivity to 5-fluorocytosine.
Persson M; Winblad B; Anséhn S; Schönebeck J
Scand J Infect Dis; 1978; 10(1):87-90. PubMed ID: 345424
[TBL] [Abstract][Full Text] [Related]
18. Decreased activity of UMP pyrophosphorylase associated with resistance to 5-fluorocytosine in Candida albicans.
Whelan WL; Kerridge D
Antimicrob Agents Chemother; 1984 Oct; 26(4):570-4. PubMed ID: 6393861
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo antifungal activity of the combination methylpartricin-5-fluorocytosine.
Strippoli V; Torosantucci A; Simonetti N
Chemioterapia; 1984 Apr; 3(2):119-25. PubMed ID: 6398120
[TBL] [Abstract][Full Text] [Related]
20. [Interactions between 5-fluorocytosine and polyene antibiotics, resp. imidazole derivatives (author's transl)].
Högl F; Raab W
Mykosen; 1981 May; 24(5):261-74. PubMed ID: 6265772
[No Abstract] [Full Text] [Related]
[Next] [New Search]
